Sakuragi N - Search Results

1

Bcl-2 expression and prognosis of patients with endometrial carcinoma.

Sakuragi N, Ohkouchi T, Hareyama H, Ikeda K, Watari H, Fujimoto T, Kuwabara M, Yamamoto R, Sagawa T, Fujino T, Fujimoto S. Sakuragi N, et al. Int J Cancer. 1998 Apr 17;79(2):153-8. doi: 10.1002/(sici)1097-0215(19980417)79:2<153::aid-ijc10>3.0.co;2-b. Int J Cancer. 1998. PMID: 9583730

2

Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma.

Ebina Y, Sakuragi N, Hareyama H, Todo Y, Nomura E, Takeda M, Okamoto K, Yamada H, Yamamoto R, Fujimoto S. Ebina Y, et al. Among authors: sakuragi n. Acta Obstet Gynecol Scand. 2002 May;81(5):458-65. doi: 10.1034/j.1600-0412.2002.810514.x. Acta Obstet Gynecol Scand. 2002. PMID: 12027821 Free article.

3

Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.

Ohkouchi T, Sakuragi N, Watari H, Nomura E, Todo Y, Yamada H, Fujimoto S. Ohkouchi T, et al. Among authors: sakuragi n. Am J Obstet Gynecol. 2002 Aug;187(2):353-9. doi: 10.1067/mob.2002.123203. Am J Obstet Gynecol. 2002. PMID: 12193924

4

Bax, Bcl-2, and p53 expression in endometrial cancer.

Sakuragi N, Salah-eldin AE, Watari H, Itoh T, Inoue S, Moriuchi T, Fujimoto S. Sakuragi N, et al. Gynecol Oncol. 2002 Sep;86(3):288-96. doi: 10.1006/gyno.2002.6742. Gynecol Oncol. 2002. PMID: 12217750

5

Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer.

Sakuragi N, Watari H, Ebina Y, Yamamoto R, Steiner E, Koelbl H, Yano M, Tada M, Moriuchi T. Sakuragi N, et al. Int J Cancer. 2005 Sep 10;116(4):514-9. doi: 10.1002/ijc.21097. Int J Cancer. 2005. PMID: 15825182

6

A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report.

Mitamura T, Watari H, Todo Y, Koshida T, Sakuragi N. Mitamura T, et al. Among authors: sakuragi n. Int J Gynecol Cancer. 2009 Jul;19(5):896-7. doi: 10.1111/IGC.0b013e3181a8342a. Int J Gynecol Cancer. 2009. PMID: 19574781

7

Extracorporeal spread and its prognostic impact in stages I and II (FIGO) endometrial carcinoma.

Sakuragi N, Tanaka T, Satoh C, Nishiya M, Ohkouchi T, Tsumura N, Takeda N, Hirahatake K, Sagawa T, Ohkubo H, et al. Sakuragi N, et al. Asia Oceania J Obstet Gynaecol. 1991 Sep;17(3):193-201. doi: 10.1111/j.1447-0756.1991.tb00260.x. Asia Oceania J Obstet Gynaecol. 1991. PMID: 1953428

8

[Abnormal E-cadherin expression as a risk factor for deep myometrial invasion and lymph node metastasis in endometrial carcinoma].

Nomura E, Sakuragi N, Fujimoto S. Nomura E, et al. Among authors: sakuragi n. Nihon Rinsho. 1995 Jul;53(7):1607-12. Nihon Rinsho. 1995. PMID: 7629996 Japanese.

9

A comparison between the preoperative and operative findings of peritoneal cytology in patients with endometrial cancer.

Sagawa T, Yamada H, Sakuragi N, Fujimoto S. Sagawa T, et al. Among authors: sakuragi n. Asia Oceania J Obstet Gynaecol. 1994 Mar;20(1):39-47. doi: 10.1111/j.1447-0756.1994.tb00419.x. Asia Oceania J Obstet Gynaecol. 1994. PMID: 8172526

10

Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.

Sakuragi N, Nishiya M, Ikeda K, Ohkouch T, Furth EE, Hareyama H, Satoh C, Fujimoto S. Sakuragi N, et al. Gynecol Oncol. 1994 May;53(2):183-9. doi: 10.1006/gyno.1994.1113. Gynecol Oncol. 1994. PMID: 8188077 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters